Lack of utility of CK-MB in combination with troponin I for the diagnosis of acute coronary syndrome
- 20 June 2020
- journal article
- letter
- Published by Springer Science and Business Media LLC in Internal and Emergency Medicine
- Vol. 15 (7), 1345-1346
- https://doi.org/10.1007/s11739-020-02399-9
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Eliminating Creatine Kinase–Myocardial Band Testing in Suspected Acute Coronary SyndromeJAMA Internal Medicine, 2017
- How Well Do Laboratories Adhere to Recommended Clinical Guidelines for the Management of Myocardial Infarction: The CARdiac MArker Guidelines Uptake in Europe Study (CARMAGUE)Clinical Chemistry, 2016
- The clinical utility of CK-MB measurement in patients suspected of acute coronary syndromeClinica Chimica Acta; International Journal of Clinical Chemistry, 2016
- 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevationEuropean Heart Journal, 2015
- Clinical and financial impact of removing creatine kinase-MB from the routine testing menu in the emergency settingThe American Journal of Emergency Medicine, 2015
- CorrectionJournal of the American College of Cardiology, 2014
- 2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary SyndromesCirculation, 2014
- The diagnostic and prognostic impact of the redefinition of acute myocardial infarction: Lessons from the Global Registry of Acute Coronary Events (GRACE)American Heart Journal, 2006
- Frequency and Clinical Implications of Discordant Creatine Kinase-MB and Troponin Measurements in Acute Coronary SyndromesJournal of the American College of Cardiology, 2006